614 results Joost van 't Hof Junior Associate Amsterdam Tom Barkhuysen Partner Amsterdam Tom Barkhuysen Partner Amsterdam Carl Wettinck Senior Associate Brussels FAQ: Wat houdt de energiebesparingsverplichting op grond van het Activiteitenbesluit milieubeheer vandaag de dag in en welke wijzigingen gelden per 1 juli 2023? Op dit moment verplicht artikel 2.15 Activiteitenbesluit drijvers van zogenoemde type A en type B inrichtingen om alle energiebesparende maatregelen te treffen met een terugverdientijd van vijf jaar of minder. FAQ: What does the energy savings obligation under the Activities Environmental Management Decree mean today and what changes will apply as of 1 July 2023? Article 2.15 of the Activities Decree currently requires operators of so-called Type A and Type B establishments to implement all energy saving measures with a payback period of five years or less. The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests. Abuse of economic dependence does not require contractual relationship On 20 February 2025, the Belgian Supreme Court confirmed that under Belgian law an abuse of economic dependence may be found even in a situation where there is no contractual relationship between the companies involved. C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here. The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. Late bewijsinbreng bij boetebesluiten: (on)mogelijk? De Afdeling deed op 29 mei 2024 een uitspraak over bewijsinbreng voor een overtreding na voltooiing van de boetebesluitvorming. In dit blog gaan wij mede aan de hand van deze uitspraak in op de (on)mogelijkheid van late bewijsinbreng bij boetebesluiten. Tom Verdonk Associate Amsterdam Ali al Khatib Senior Associate Amsterdam Tim de Greve Partner Amsterdam Stibbe advises Jumbo family Van Eerd on acquisition of Hema Stibbe advised Mississippi Ventures, the investment vehicle of the Van Eerd family (owners of supermarket chain Jumbo), on the acquisition of the remaining 50 per cent of the shares in HEMA. Pagination Previous page Page 32 Page 33 Current page 34 Page 35 Next page
FAQ: Wat houdt de energiebesparingsverplichting op grond van het Activiteitenbesluit milieubeheer vandaag de dag in en welke wijzigingen gelden per 1 juli 2023? Op dit moment verplicht artikel 2.15 Activiteitenbesluit drijvers van zogenoemde type A en type B inrichtingen om alle energiebesparende maatregelen te treffen met een terugverdientijd van vijf jaar of minder.
FAQ: What does the energy savings obligation under the Activities Environmental Management Decree mean today and what changes will apply as of 1 July 2023? Article 2.15 of the Activities Decree currently requires operators of so-called Type A and Type B establishments to implement all energy saving measures with a payback period of five years or less.
The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.
Abuse of economic dependence does not require contractual relationship On 20 February 2025, the Belgian Supreme Court confirmed that under Belgian law an abuse of economic dependence may be found even in a situation where there is no contractual relationship between the companies involved.
C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here.
The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
Late bewijsinbreng bij boetebesluiten: (on)mogelijk? De Afdeling deed op 29 mei 2024 een uitspraak over bewijsinbreng voor een overtreding na voltooiing van de boetebesluitvorming. In dit blog gaan wij mede aan de hand van deze uitspraak in op de (on)mogelijkheid van late bewijsinbreng bij boetebesluiten.
Stibbe advises Jumbo family Van Eerd on acquisition of Hema Stibbe advised Mississippi Ventures, the investment vehicle of the Van Eerd family (owners of supermarket chain Jumbo), on the acquisition of the remaining 50 per cent of the shares in HEMA.